Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Solid Biosciences Inc. (SLDB) had Return on Tangible Equity of -75.91% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-96.02M |
|
-- |
|
-- |
|
$104.25M |
|
$-104.25M |
|
$8.24M |
|
$-96.02M |
|
$-96.02M |
|
$-96.02M |
|
$-96.02M |
|
$-96.02M |
|
$-96.02M |
|
$-104.25M |
|
$-104.08M |
|
19.88M |
|
19.88M |
|
$-4.83 |
|
$-4.83 |
|
| Balance Sheet Financials | |
$129.73M |
|
$6.62M |
|
$35.20M |
|
$164.94M |
|
$14.52M |
|
$1.23M |
|
$23.94M |
|
$38.46M |
|
$126.48M |
|
$126.48M |
|
$126.48M |
|
20.39M |
|
| Cash Flow Statement Financials | |
$-94.18M |
|
$9.69M |
|
$3.12M |
|
$157.22M |
|
$75.85M |
|
$-81.37M |
|
$7.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.94 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-95.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-75.91% |
|
|
Return on Tangible Equity |
-75.91% |
-58.21% |
|
-75.18% |
|
$6.20 |
|
$-4.81 |
|
$-4.74 |
|